TL;DR
This paper introduces PETCH-DB, a novel database that centralizes and makes accessible data on 5-hydroxymethylcytosine (5hmC) modifications, a crucial epigenetic mark with significant implications for disease. By integrating data from the innovative 5hmC-Seal technique, PETCH-DB aims to accelerate research into epigenetic biomarkers for complex diseases and tissue-specific gene regulation.
What Problem Does This Paper Address?
Epigenetic modifications, particularly DNA methylation (5mC), are fundamental to gene regulation and disease. However, 5mC is often studied without distinguishing it from other modified cytosines, such as 5-hydroxymethylcytosines (5hmC). 5hmC has a distinct genomic distribution and regulatory role, often associated with active gene expression, and shows promise as a non-invasive biomarker in circulating cell-free DNA (cfDNA) for early disease detection and prognosis. Traditional epigenomic profiling methods struggle to differentiate between 5mC and 5hmC. While the 5hmC-Seal technique offers a sensitive solution for genome-wide 5hmC profiling, the accumulating data from this method needs a centralized platform for easy access, validation, and re-use by the research community. PETCH-DB addresses this gap by providing a dedicated portal for 5hmC-Seal data, facilitating the exploration of tissue-specific patterns and disease associations.
Methods
The PETCH-DB database was built using a modular and extensible architecture, implemented with the Flask web development framework (v2.0.2) in Python. It is hosted on Amazon Elastic Compute Cloud and utilizes a high-performance HTTP server, NGINX (v1.18.0), with Gunicorn as the web server gateway interface. The data is stored in Amazon Simple Storage Service and Amazon Relational Database Service for MySQL (v8.0). The user interface was developed using HTML, CSS, jQuery, and JavaScript, offering an accessible way to query and visualize the data. The underlying 5hmC-Seal sequencing data was processed using published bioinformatic pipelines and summarized for gene bodies annotated by GENCODE (v15) for the human genome reference (hg19). The DESeq2 package was employed for normalizing raw count data and determining gene bodies based on customized thresholds.
Datasets
The PETCH-DB currently showcases data from two main sources:
- Human Tissue Map: Genome-wide 5hmC data from 19 fresh-frozen tissue specimens across 10 organ systems, collected from five non-cancer donors. This dataset (GSE144530) was generated using the 5hmC-Seal technique and provides insights into tissue-specific 5hmC modifications.
- Cancer Biomarker Discovery: Differential analysis results from circulating cfDNA of two case-control studies:
- Hepatocellular Carcinoma (HCC): Data from approximately 1200 HCC patients and 900 healthy controls (GSE112679).
- Glioblastoma (GBM): Data from approximately 110 GBM patients and 110 healthy controls (GSE132118).
The raw 5hmC-Seal sequencing data for these studies are publicly available on the NCBI Gene Expression Omnibus (GEO) database.
Key Insights and Ideas
- 5hmC as a Distinct Epigenetic Mark: The paper emphasizes that 5hmC is not merely an intermediate in DNA demethylation but a functionally distinct epigenetic mark with unique genomic distribution and regulatory roles, often linked to active gene expression.
- Biomarker Potential of 5hmC in cfDNA: The 5hmC-Seal technique, coupled with cfDNA analysis, offers a powerful, non-invasive approach for early disease detection and prognosis, particularly for complex diseases like cancer and diabetes.
- Tissue Specificity of 5hmC: The Human Tissue Map data highlights that 5hmC modifications exhibit significant tissue specificity, which can be valuable for understanding tissue-specific gene regulation and potentially for determining tumor origin.
- Centralized Data Access is Crucial: The creation of PETCH-DB underscores the need for a consolidated platform to manage and disseminate the growing body of 5hmC-Seal data, thereby fostering collaboration and accelerating research.
Key Results
PETCH-DB (v1.0) provides users with:
- Interactive Exploration: Users can search for specific genes or genomic regions to view 5hmC modification levels across different tissue types (Human Tissue Map) or compare cases and controls in cancer studies (Cancer Biomarker Discovery).
- Visualization Tools: The database offers heatmaps, box plots, and genome peak tracks to visualize 5hmC data and differential analysis results.
- Data Download: Raw results and supporting documents are available for download, enabling further in-depth analysis.
- GeneCards Integration: Search results are linked to GeneCards for detailed gene information.
- Application Examples: The paper demonstrates the utility of PETCH-DB with examples like identifying brain-specific 5hmC patterns for the PRR15 gene and confirming higher 5hmC levels of the ESRRG gene in liver cancer patients.
Limitations and Future Work
- Data Expansion: The authors plan to regularly update PETCH-DB with accumulating data from ongoing and future research projects, including additional cancer types, complex diseases, and clinical outcomes.
- Future Extensions: Potential future extensions include incorporating more complex diseases, additional genomic characteristics (e.g., promoter regions, long non-coding RNAs), and subtyping/prognosis data.
- Technical Challenges: The authors acknowledge that issues like technical batch effects and sample authentication may present challenges for future data integration.
- Individual-Level Data: For detailed individual-level sample information (e.g., tumor stage, age, gender), users are directed to contact the corresponding authors of the respective publications.
Summary updated